Literature DB >> 10981928

Work experience in adolescents with spinal cord injuries.

C J Anderson1, L C Vogel.   

Abstract

The purpose of this study is to compare the work experiences of adolescents with spinal cord injuries (SCI) to peers without disabilities. Twenty-eight adolescents with SCI and 25 age-matched individuals without disabilities (controls) took part in the study.A structured telephone questionnaire was used to assess their experience of household chores, volunteer jobs, and paid work. The mean age at interview was 16.2 years for those with SCI and 16.0 years for control participants. There was no significant difference between the individuals with SCI and the control participants in chores or volunteer work experiences, but the individuals with SCI were significantly less likely to have paid work experience than control participants (chi2 = 13.670, p<0.001). Of the older adolescents, aged >15 to 19 years, five of 15 individuals with SCI and 16 of 16 control participants had paid work (Fisher exact test p<0.001). Of individuals with SCI, those with milder injuries and those injured at a younger age were more likely to have work experience.

Entities:  

Mesh:

Year:  2000        PMID: 10981928     DOI: 10.1017/s0012162200000980

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  2 in total

1.  Stability of transition to adulthood among individuals with pediatric-onset spinal cord injuries.

Authors:  Caroline J Anderson; Lawrence C Vogel; Kathleen M Willis; Randal R Betz
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

2.  European study of frequency of participation of adolescents with and without cerebral palsy.

Authors:  Susan I Michelsen; Esben M Flachs; Mogens T Damsgaard; Jacqueline Parkes; Kathryn Parkinson; Marion Rapp; Catherine Arnaud; Malin Nystrand; Allan Colver; Jerome Fauconnier; Heather O Dickinson; Marco Marcelli; Peter Uldall
Journal:  Eur J Paediatr Neurol       Date:  2013-12-25       Impact factor: 3.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.